Skip to Content

Pharmaceutical Sales 2004

The following is a list of the top 200 pharmaceutical drugs by retail sales in 2004, listed by U.S. sales value and brand name.
Quarterly top 100 prescription sales data now available, from Q1 2011.

Top 200 Drugs for 2004 by Sales

(By Units)

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012

Rank Drug Current Manufacturer Total Sales ($000) % Change 2003
1 Lipitor Pfizer Inc. 5,959,955 10.9%
2 Prevacid Takeda Pharmaceuticals U.S.A., Inc. 3,197,890 -4.8%
3 Zocor Merck 3,150,892 2.8%
4 Nexium AstraZeneca 2,963,518 19.0%
5 Zoloft Pfizer Inc. 2,622,801 6.6%
6 Advair Diskus GlaxoSmithKline 2,323,170 22.7%
7 Effexor XR Pfizer Inc. 2,281,014 19.4%
8 Plavix Bristol-Myers Squibb Company 2,169,479 30.4%
9 Celebrex Pfizer Inc. 2,114,734 6.0%
10 Neurontin Pfizer Inc. 2,000,077 3.1%
11 Protonix Pfizer Inc. 1,910,067 26.8%
12 Norvasc Pfizer Inc. 1,883,014 9.8%
13 Zyprexa Eli Lilly and Company 1,881,354 -8.8%
14 Singulair Merck 1,849,025 24.2%
15 Ambien Pfizer Inc. 1,719,253 18.3%
16 OxyContin Purdue Pharma LP 1,700,737 0.0%
17 Lexapro Actavis Pharma, Inc. 1,551,230 69.2%
18 Pravachol Bristol-Myers Squibb Company 1,522,955 -3.7%
19 Fosamax Merck 1,463,390 6.8%
20 Risperdal Janssen Pharmaceuticals, Inc. 1,436,891 1.9%
21 Actos Takeda Pharmaceuticals U.S.A., Inc. 1,388,002 12.5%
22 Seroquel AstraZeneca 1,378,038 30.4%
23 Allegra Sanofi 1,260,443 -6.6%
24 Duragesic Janssen Pharmaceuticals, Inc. 1,208,391 22.4%
25 Aciphex Eisai Inc. 1,139,155 8.8%
26 Levaquin Janssen Pharmaceuticals, Inc. 1,128,679 8.0%
27 Vioxx Merck 1,088,453 -28.0%
28 Toprol XL AstraZeneca 1,075,725 22.0%
29 Zithromax Z-Pak Pfizer Inc. 1,070,535 -4.2%
30 Avandia GlaxoSmithKline 1,054,786 9.0%
31 Bextra Pfizer Inc. 1,053,079 28.2%
32 Topamax Janssen Pharmaceuticals, Inc. 1,052,107 24.0%
33 Zyrtec Johnson & Johnson Consumer Inc. 1,015,113 -2.1%
34 Lotrel Novartis Pharmaceuticals Corporation 970,827 20.4%
35 Enbrel Amgen Inc. 955,266 22.5%
36 Wellbutrin XL Bausch Health Companies Inc. 948,683 915.9%
37 Flonase GlaxoSmithKline 930,267 11.3%
38 Viagra Pfizer Inc. 906,580 -19.2%
39 Synthroid Abbott Laboratories 873,282 -1.1%
40 Celexa Actavis Pharma, Inc. 856,665 -29.5%
41 Paxil CR Apotex Corp. 824,433 15.4%
42 Valtrex GlaxoSmithKline 801,721 31.8%
43 Lamictal GlaxoSmithKline 780,614 44.0%
44 Imitrex Oral GlaxoSmithKline 780,613 1.9%
45 Adderall XR Takeda Pharmaceuticals U.S.A., Inc. 777,879 38.1%
46 Concerta Janssen Pharmaceuticals, Inc. 764,317 24.3%
47 Abilify Bristol-Myers Squibb Company 747,400 115.1%
48 Diovan Novartis Pharmaceuticals Corporation 723,821 21.2%
49 Premarin Tabs Pfizer Inc. 702,872 -18.0%
50 Zetia Merck 687,673 104.8%
51 Tricor Abbott Laboratories 684,984 28.8%
52 Actonel Actavis Pharma, Inc. 682,554 47.1%
53 Altace King Pharmaceuticals, Inc. 659,710 11.5%
54 Strattera Eli Lilly and Company 646,238 87.3%
55 Diovan HCT Novartis Pharmaceuticals Corporation 627,878 29.8%
56 Coreg GlaxoSmithKline 626,189 36.4%
57 Lamisil Oral Novartis Pharmaceuticals Corporation 603,003 11.6%
58 Depakote Abbott Laboratories 588,935 -1.6%
59 Aricept Eisai Inc. 584,302 18.5%
60 Cozaar Merck 558,232 7.8%
61 Evista Eli Lilly and Company 544,966 -1.2%
62 Flomax Boehringer Ingelheim Pharmaceuticals, Inc. 541,800 4.9%
63 Lantus Sanofi 537,299 54.2%
64 Wellbutrin SR GlaxoSmithKline 529,332 -66.8%
65 Detrol LA Pfizer Inc. 507,354 14.8%
66 Crestor AstraZeneca 503,011 >999
67 Nasonex Merck 498,730 1.5%
68 Clarinex Merck 498,199 -18.9%
69 Zofran GlaxoSmithKline 495,657 15.9%
70 Accupril Pfizer Inc. 457,876 -10.7%
71 Flovent GlaxoSmithKline 456,600 -8.8%
72 Combivent Boehringer Ingelheim Pharmaceuticals, Inc. 454,028 15.5%
73 Humalog Eli Lilly and Company 435,911 4.0%
74 Combivir GlaxoSmithKline 433,516 5.3%
75 Pulmicort Respules AstraZeneca 430,807 21.5%
76 Hyzaar Merck 427,072 11.4%
77 Mobic Abbott Laboratories 421,165 60.4%
78 Ortho Evra Janssen Pharmaceuticals, Inc. 411,189 23.2%
79 Procrit Janssen Biotech, Inc. 406,212 -3.2%
80 Allegra-D Dr. Reddy's Laboratories, Inc. 403,507 -8.1%
81 Cellcept Genentech, Inc. 399,650 15.5%
82 Skelaxin Elan Corporation plc 399,381 8.6%
83 Trileptal Novartis Pharmaceuticals Corporation 399,001 27.7%
84 Xalatan Pfizer Inc. 390,196 7.5%
85 Omnicef Abbott Laboratories 381,124 26.8%
86 Prograf Astellas Pharma US, Inc. 362,051 20.5%
87 Viread Gilead Sciences, Inc. 350,319 34.5%
88 Provigil Cephalon, Inc. 348,785 36.4%
89 Elidel Novartis Pharmaceuticals Corporation 347,733 43.8%
90 Geodon Oral Pfizer Inc. 337,826 35.2%
91 Ditropan XL Janssen Pharmaceuticals, Inc. 335,038 2.3%
92 Lovenox Sanofi 330,773 8.8%
93 Zithromax Pfizer Inc. 330,200 28.6%
94 Avandamet GlaxoSmithKline 330,146 192.8%
95 Yasmin 28 Bayer HealthCare Pharmaceuticals Inc. 327,574 51.8%
96 Depakote ER Abbott Laboratories 326,183 35.1%
97 Avapro Bristol-Myers Squibb Company 323,367 12.3%
98 Asacol Actavis Pharma, Inc. 322,219 7.4%
99 Ultracet Janssen Pharmaceuticals, Inc. 321,984 16.4%
100 Lidoderm Endo Pharmaceuticals Inc. 313,786 69.0%
101 Diflucan Pfizer Inc. 312,619 -27.9%
102 Nasacort AQ Sanofi 309,590 9.5%
103 Rhinocort Aqua AstraZeneca 307,406 6.0%
104 Sustiva Bristol-Myers Squibb Company 296,783 15.5%
105 Trizivir GlaxoSmithKline 291,605 -1.2%
106 Levoxyl King Pharmaceuticals, Inc. 291,498 -17.3%
107 Zithromax Susp 289,444 -6.9%
108 Kaletra Abbott Laboratories 289,392 3.9%
109 Keppra UCB, Inc. 288,777 42.1%
110 Humira Abbott Laboratories 286,283 109.6%
111 Niaspan Abbott Laboratories 285,880 49.6%
112 Ortho Tri-Cyclen Janssen Pharmaceuticals, Inc. 283,274 -62.6%
113 Avonex Biogen 280,874 -0.1%
114 Amaryl Sanofi 278,094 18.2%
115 Copaxone Accredo Health Group, Inc. 275,838 -0.6%
116 Prilosec AstraZeneca 266,809 -64.3%
117 Metformin HCl ER 265,898 >999
118 Actiq Abbott Laboratories 262,320 32.4%
119 Patanol Alcon 257,327 4.8%
120 Coumadin Tabs Bristol-Myers Squibb Company 253,341 -10.2%
121 Zelnorm Novartis Pharmaceuticals Corporation 251,846 89.4%
122 Ortho Tri-Cyclen Lo Janssen Pharmaceuticals, Inc. 247,173 160.8%
123 Biaxin XL Abbott Laboratories 244,968 -16.2%
124 AndroGel Abbott Laboratories 242,917 10.7%
125 Arimidex AstraZeneca 240,802 48.4%
126 Glucovance Bristol-Myers Squibb Company 240,686 -44.5%
127 Cefzil Bristol-Myers Squibb Company 240,520 -22.8%
128 Xopenex Akorn, Inc. 240,430 14.9%
129 Avelox Bayer HealthCare Pharmaceuticals Inc. 235,322 4.6%
130 Augmentin XR Dr. Reddy's Laboratories, Inc. 233,839 14.0%
131 Proscar Merck 233,194 8.2%
132 Endocet Endo Pharmaceuticals Inc. 231,148 90.8%
133 Reyataz Bristol-Myers Squibb Company 228,081 357.3%
134 Avalide Bristol-Myers Squibb Company 225,070 32.9%
135 Lescol XL Novartis Pharmaceuticals Corporation 218,382 10.7%
136 Norvir Abbott Laboratories 211,971 440.6%
137 Aldara Medicis Pharmaceutical Corporation 210,160 23.3%
138 Gleevec Novartis Pharmaceuticals Corporation 208,952 34.2%
139 Zyrtec Syrup 208,884 -1.7%
140 Budeprion SR Teva Pharmaceuticals USA, Inc. 203,954 NA
141 Epivir GlaxoSmithKline 202,566 -1.1%
142 Miacalcin Nasal Mylan Pharmaceuticals Inc. 201,855 0.1%
143 Augmentin ES-600 Dr. Reddy's Laboratories, Inc. 201,822 -23.3%
144 Serevent Diskus GlaxoSmithKline 200,636 48.7%
145 Trinessa Actavis Pharma, Inc. 195,038 >999
146 Pegasys Genentech, Inc. 191,754 41.3%
147 Accutane Roche 191,441 -29.7%
148 Alphagan P Actavis Pharma, Inc. 189,749 -4.0%
149 Klor-Con Sandoz Inc. 189,304 -5.5%
150 BenzaClin Sanofi 189,081 6.8%
151 Humalog Mix 75/25 Pn 189,024 -11.6%
152 Biaxin Abbott Laboratories 187,485 -15.4%
153 Humulin N Eli Lilly and Company 185,325 -17.8%
154 Amnesteem Mylan Pharmaceuticals Inc. 184,826 -3.6%
155 Inderal LA Wyeth 184,484 -1.2%
156 Prozac Eli Lilly and Company 181,717 -18.2%
157 Cipro Bayer HealthCare Pharmaceuticals Inc. 181,254 -73.1%
158 Benicar Daiichi Sankyo 177,847 91.6%
159 Cosopt Akorn, Inc. 176,797 10.5%
160 Famvir GlaxoSmithKline 175,962 3.2%
161 RenaGel Genzyme Corporation 175,737 19.9%
162 DDAVP Sanofi 175,548 9.4%
163 Cialis Eli Lilly and Company 174,849 >999
164 Paxil Apotex Corp. 171,499 -87.3%
165 Casodex AstraZeneca 171,366 3.9%
166 Thalomid Bristol-Myers Squibb Company 169,566 31.7%
167 Arava Sanofi 168,839 14.0%
168 Zofran ODT GlaxoSmithKline 164,910 61.9%
169 Forteo Eli Lilly and Company 163,148 214.5%
170 Namenda Actavis Pharma, Inc. 161,930 >999
171 Zyrtec-D Johnson & Johnson Consumer Inc. 161,758 2.3%
172 Differin Galderma Laboratories, L.P. 161,587 3.9%
173 Betaseron Bayer HealthCare Pharmaceuticals Inc. 159,381 2.1%
174 Neupogen Amgen Inc. 157,428 -16.1%
175 Zomig AstraZeneca 157,216 -9.2%
176 Temodar Merck 155,938 19.6%
177 Catapres-TTS Boehringer Ingelheim Pharmaceuticals, Inc. 154,143 7.8%
178 Tobradex Alcon 153,757 -4.2%
179 Atacand AstraZeneca 153,224 -2.1%
180 Humulin 70/30 Eli Lilly and Company 152,321 -15.2%
181 Lumigan Actavis Pharma, Inc. 148,024 18.8%
182 Mirapex Boehringer Ingelheim Pharmaceuticals, Inc. 143,300 11.6%
183 Tussionex Sanofi 140,072 -5.3%
184 Xeloda Genentech, Inc. 139,676 8.2%
185 Reminyl Johnson & Johnson Consumer Inc. 138,931 17.7%
186 Exelon Novartis Pharmaceuticals Corporation 138,094 -4.5%
187 Prempro Pfizer Inc. 137,847 -37.3%
188 DuoNeb Dey Pharma 134,801 51.3%
189 Rebif Pfizer Inc. 134,198 23.2%
190 Dovonex Bristol-Myers Squibb Company 134,137 -1.6%
191 Imitrex Inj 133,684 -20.8%
192 Zonegran Eisai Inc. 133,600 39.5%
193 Pletal Pfizer Inc. 132,987 -0.4%
194 Fuzeon Genentech, Inc. 129,369 416.3%
195 Plendil AstraZeneca 129,306 -15.4%
196 Iressa AstraZeneca 128,419 146.4%
197 Aviane Teva Pharmaceuticals USA, Inc. 127,726 3.9%
198 Viramune Boehringer Ingelheim Pharmaceuticals, Inc. 127,683 5.3%
199 Tequin Bristol-Myers Squibb Company 127,612 -19.2%
200 Zerit Bristol-Myers Squibb Company 126,427 -22.1%
All Others 24,121,195 -6.8%

Source: Verispan, VONA

(By Units)

View data for: 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012